hero media helmsley

Understanding and Preventing Hypoglycemia in Diabetes

Madrid, Spain | Monday, September 9, 2024

Helmsley’s Type 1 Diabetes Program will host a one-day industry session on the occasion of the 60th Annual Meeting of the European Association for the Study of Diabetes.

Join us for this scientific meeting exploring the latest research in how alpha and delta cell dysfunction leads to hypoglycemia, and efforts to therapeutically restore the body’s ability to reverse it. Session themes will include:

  • Genetic and gene expression studies that aim to understand the cause of glucagon secretion defects in diabetes.
  • Understanding and restoring alpha cell function in type 1 diabetes and type 2 diabetes.
    • Intrinsic, paracrine, and in vivo consequences in humans.
  • Clinical progress and regulatory perspectives regarding pharmacological strategies to prevent hypoglycemia.
  • Short talks and a poster session from submitted abstracts.

 

Check back here soon for additional details about the event. Note that this meeting is intended to focus on islet biology and the physiological response to hypoglycemia and not, for example, on automated insulin delivery, novel insulins, or beta cell replacement.

Scientific Organizing Committee

 

Marcela Brissova, PhD, Vanderbilt University Medical Center, United States

Shareen Forbes, MBChB, PhD, FRCP, University of Edinburgh, Scotland

Patrick Gilon, PhD, Université Catholique de Louvain, Belgium

Philippe Lysy, MD, PhD, Université Catholique de Louvain, Belgium

David Piston, PhD, Washington University in St. Louis, United States

Patrik Rorsman, PhD, Oxford University, England

Jason Winnick, PhD, University of Cincinnati, United States

Gina Yosten, PhD, St. Louis University School of Medicine, United States

Conchi Izquierdo, PhD, Helmsley Charitable Trust, United States

Benjamin Williams, PhD, Helmsley Charitable Trust, United States

Registration

 

Advance registration requested

We encourage those interested in attending to register in advance. Note that in-person admission will be on a first-come, first-served basis, and registration is required to attend the Helmsley session lunch. Virtual participation will be available for those unable to attend in-person.

Registration form

Note that separate registration for the EASD meeting is also required to attend. If you would like to register only for the one-day industry session, please email exh_reg_easd@interplan.de for more information.

Abstract Submission

 

Abstracts submissions are invited to be considered by the scientific committee for a poster session and short talks. Abstracts selected for short talks will be compensated with a travel award.

Submission guidelines are provided at the link below. The submission deadline is May 30, 2024.

Abstract submission guidelines

Abstract submission form

 

Questions or concerns?

 

Please contact hypoglycemia@helmsleytrust.org.

 

More about Helmsley

More about Helmsley's Type 1 Diabetes Program

The Type 1 Diabetes (T1D) program is dedicated to helping the global T1D community live safer, better, and more fulfilling lives today while funding advancements in research and technology for a better tomorrow.